Delivery Order SPE2DB22D3301-SPE2DB25FY9UL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,040.59 to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count packages) on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. FYCOMPA (perampanel) is a neurological medication used as an adjunctive treatment for epilepsy and seizure...
- The Defense Logistics Agency awarded a $1,604.28 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitive award, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of FYCOMPA 12 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $2,152.34. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a $4,169.69 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 6 mg tablets (30-count) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order valued at $7,307.89 to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/ml oral suspension (340ml) on July 18, 2025. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, with performance to occur at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of FYCOMPA 4 mg tablets (30-count units) with a ceiling value of $3,134.37. This firm fixed-price delivery order, which has an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of FYCOMPA 12 MG TABLET 30S, a pharmaceutical product. The firm-fixed-price contract has a ceiling value of $1,016.64 and a completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which is not set aside. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
- This is a $1,509.13 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FYCOMPA 12 MG TABLET 30S. The contract has a ceiling value of $1,509.13 and a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order valued at $1,027.44 to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count) on August 14, 2025, with completion targeted for August 15, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- This is a $1,235.33 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The delivery order is for the supply of FYCOMPA 4 MG TABLET 30S, a prescription medication, with a period of performance through August 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9ULDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,049.88 to AmerisourceBergen Drug Corp for FYCOMPA (perampanel) 10 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania. FYCOMPA is an oral anticonvulsant medication used as adjunctive therapy for partial-onset seizures and primary generalized tonic-clonic seizures in patients with epilepsy. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime vehicle enables AmerisourceBergen to serve as a comprehensive global pharmaceutical supplier for military healthcare programs, providing a wide range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/21/25 |